Michael Howell - 18 May 2023 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Scientific Officer & Head of Translational Science
Signature
/s/ Michael Howell
Issuer symbol
ZURA
Transactions as of
18 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 21:17:10 UTC
Previous filing
21 Mar 2023
Next filing
06 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZURA Class A Ordinary Shares Award $0 +114,395 $0.000000 114,395 18 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted an award of 114,395 Restricted Share Units ("RSUs") on May 18, 2023 (the "Grant Date"). Under the terms of the RSU grant, 25% of the RSUs vest on each of the anniversaries of the Grant Date, such that the RSUs vest equally over four years, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Chief Scientific Officer & Head of Translational Science